A new, free exhibition chronicling how science is transforming cancer care opens at the Science Museum in London today – featuring discoveries led by researchers at The Institute of Cancer Research, London.

A combination of two existing skin cancer drugs and a third experimental drug could lead to a new strategy for treating patients who do not respond to existing therapies, a new study in mice suggests.

New adaptive radiotherapy technique for head and neck cancer can deliver a more robust treatment plan in a shorter timeframe on MR Linac, compared with the current method used by most radiotherapy centres.